Administration of ricin induces a severe inflammatory response via nonredundant stimulation of ERK, JNK, and P38 MAPK and provides a mouse model of hemolytic uremic syndrome

被引:86
作者
Korcheva, V
Wong, J
Corless, C
Iordanov, M
Magun, B
机构
[1] Oregon Hlth & Sci Univ, Dept Cell & Dev Biol, Portland, OR 97239 USA
[2] Oregon Hlth & Sci Univ, Dept Pathol, Portland, OR 97239 USA
关键词
D O I
10.1016/S0002-9440(10)62256-0
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Recent interest in the health consequences of ricin as a weapon of terrorism has led us to investigate the effects of ricin on cells in vitro and in mice. Our previous studies showed that depurination of the 28S rRNA by ricin results in the inhibition of translation and the coordinate activation of the stress-activated protein kinases JNK and p38 MAPK. In RAW 264.7 macrophages, ricin induced the activation of ERK, JNK, and p38 MAPK, the accumulation of mRNA encoding tumor necrosis factor (TNF)-alpha, interleukin (IL)-1, the transcription factors c-Fos, c-Jun, and EGR1, and the appearance of TNF-alpha protein in the culture medium. Using specific inhibitors of MAPKs, we demonstrated the nonredundant roles of the individual MAPKs in mediating proinflammatory gene activation in response to ricin. Similarly, the intravenous administration of ricin to mice led to the activation of ERK, JNK, and p38 MAPK in the kidneys, and increases in plasma-borne TNF-alpha, IL-1beta, and IL-6. Ricin-injected mice developed the hallmarks of hemolytic uremic syndrome, including thrombotic microangiopathy, hemolytic anemia, thrombocytopenia, and acute renal failure. Microarray analyses demonstrated a massive proinflammatory transcriptional response in the kidneys, coincidental with the symptoms of hemolytic uremic syndrome. Therapeutic management of the inflammatory response may affect the outcome of intoxication by ricin.
引用
收藏
页码:323 / 339
页数:17
相关论文
共 112 条
[51]   p38 map kinases: Key signalling molecules as therapeutic targets for inflammatory diseases [J].
Kumar, S ;
Boehm, J ;
Lee, JC .
NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (09) :717-726
[52]   Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation [J].
Kyriakis, JM ;
Avruch, J .
PHYSIOLOGICAL REVIEWS, 2001, 81 (02) :807-869
[53]   Inhibition of p38 MAP kinase as a therapeutic strategy [J].
Lee, JC ;
Kumar, S ;
Griswold, DE ;
Underwood, DC ;
Votta, BJ ;
Adams, JL .
IMMUNOPHARMACOLOGY, 2000, 47 (2-3) :185-201
[54]   ATF3 gene - Genomic organization, promoter, and regulation [J].
Liang, GS ;
Wolfgang, CD ;
Chen, BPC ;
Chen, TH ;
Hai, TW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (03) :1695-1701
[55]   Circulating inflammatory cytokine levels in hemolytic uremic syndrome [J].
Litalien, C ;
Proulx, F ;
Mariscalco, MM ;
Robitaille, P ;
Turgeon, JP ;
Orrbine, E ;
Rowe, PC ;
McLaine, PN ;
Seidman, E .
PEDIATRIC NEPHROLOGY, 1999, 13 (09) :840-845
[56]   TUMOR-NECROSIS-FACTOR CONCENTRATIONS IN HEMOLYTIC-UREMIC SYNDROME PATIENTS AND CHILDREN WITH BLOODY DIARRHEA IN ARGENTINA [J].
LOPEZ, EL ;
CONTRINI, MM ;
DEVOTO, S ;
DEROSA, MF ;
GRANA, MG ;
GENERO, MH ;
CANEPA, C ;
GOMEZ, HF ;
CLEARY, TG .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1995, 14 (07) :594-598
[57]   Transcriptional regulation of the Icam-1 gene in antigen receptor- and phorbol ester-stimulated B lymphocytes: Role for transcription factor EGR1 [J].
Maltzman, JS ;
Carman, JA ;
Monroe, JG .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (04) :1747-1759
[58]  
Maltzman JS, 1996, MOL CELL BIOL, V16, P2283
[59]   MAP KINASE KINASE KINASE, MAP KINASE KINASE AND MAP KINASE [J].
MARSHALL, CJ .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 1994, 4 (01) :82-89
[60]  
Moake JL, 2002, ARCH PATHOL LAB MED, V126, P1430